Latest News for: central nervous system

Edit

Central Nervous System Therapeutic Market is Set to Hit US$ 235.87 Billion by 2033 | ...

Nasdaq Globe Newswire 04 Sep 2025
.
Edit

Apertura Gene Therapy Licenses Blood-Brain Barrier-Penetrant AAV Capsid to Multiple Partners Advancing Central Nervous System Treatments

PR Newswire 13 Aug 2025
... several licensing deals with Galibra Neuroscience and Emugen Therapeutics to utilize Apertura's human transferrin receptor 1 capsid (TfR1 CapX) for their central nervous system (CNS) programs.
Edit

CENTRAL NERVOUS SYSTEM DEPRESSANT Country Song by RICH VERNADEAU

Rumble 24 Jul 2025
Click the Rumble article link to see the video ....
Edit

Central Nervous System Collaboration and Licensing Agreement Analysis Report 2025 with Directory of 811 Deals ...

Nasdaq Globe Newswire 21 Jul 2025
Central Nervous System Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the central nervous ...
Edit

Medical Devices: Immunology and Microbiology Devices; Classification of the Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections (The eRulemaking Program)

Public Technologies 26 Jun 2025
A herpes simplex virus nucleic acid-based assay for central nervous system infections is a qualitative in vitro diagnostic device intended for the detection and differentiation of HSV-1 and HSV-2 in ...
Edit

Opportunities in the Central Nervous System (CNS) Therapeutics Market: Revenues Forecast to Reach US$156.5 Billion ...

Nasdaq Globe Newswire 16 Jun 2025
.
  • 1

Article Search

tools
×
×
×
×